Welcome to LookChem.com Sign In|Join Free
  • or
[1-(3-fluoro-2'-methanesulfonyl-biphenyl-4-ylcarbamoyl)-cyclopropyl]-carbamic acid tert-butyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

675833-69-9

Post Buying Request

675833-69-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

675833-69-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 675833-69-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,5,8,3 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 675833-69:
(8*6)+(7*7)+(6*5)+(5*8)+(4*3)+(3*3)+(2*6)+(1*9)=209
209 % 10 = 9
So 675833-69-9 is a valid CAS Registry Number.

675833-69-9Relevant academic research and scientific papers

The discovery of glycine and related amino acid-based factor Xa inhibitors

Kohrt, Jeffrey T.,Filipski, Kevin J.,Cody, Wayne L.,Bigge, Christopher F.,La, Frances,Welch, Kathleen,Dahring, Tawny,Bryant, John W.,Leonard, Daniele,Bolton, Gary,Narasimhan, Lakshmi,Zhang, Erli,Peterson, J. Thomas,Haarer, Staci,Sahasrabudhe, Vaishali,Janiczek, Nancy,Desiraju, Shrilakshmi,Hena, Mostofa,Fiakpui, Charles,Saraswat, Neerja,Sharma, Raman,Sun, Shaoyi,Maiti, Samarendra N.,Leadley, Robert,Edmunds, Jeremy J.

, p. 4379 - 4392 (2007/10/03)

Herein, we report on the identification of three potent glycine and related amino acid-based series of FXa inhibitors containing a neutral P1 chlorophenyl pharmacophore. A X-ray crystal structure has shown that constrained glycine derivatives with optimiz

INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE

-

Page 64, (2010/02/06)

This invention discloses amino acid derivatives which display inhibitory effects on the serine protease factor Xa. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, methods for the preparation of the compounds, and methods of using them as therapeutic agents for treating or preventing disease states in mammals characterized by abnormal thrombosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 675833-69-9